Researchers have found that the enzyme PKCzeta controls the activation of a pro-tumor gene called c-Myc. Normally, PKCzeta’s alteration keeps c-Myc in check. But PKCzeta levels are low in prostate and other cancers, leaving c-Myc free to enhance cell growth and metastasis.
Read More...Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5106)
- Cancer Treatment (1201)
- Colon Rectal Cancer (5951)
- General Cancer (16813)
- Leukemia Lymphoma Cancer (10572)
- Lung Mesothelioma Asbestos (4826)
- Ovarian Cervical Uterine Cancer (1137)
- Pancreatic Cancer (56)
- Prostate Cancer (6895)
- Skin Cancer (6030)
- Uncategorized (53)
-
Cancer News Topics
- Poliovirus vaccine trial shows early promise for recurrent glioblastoma
- Scientists uncover how grapefruits provide a secret weapon in medical drug delivery
- Radioactive nanoparticles target cancer cells
- Racial disparities seen in U.S. lung cancer treatment
- Ease Cancer Stress, Anxiety with ‘Emotional Wellness Toolbox’
- Asbestos Contributes to Overall Failing Grades of New Jersey School District According to Architect Reports
- How gold nanoparticles can help fight ovarian cancer
- Hong Kong women weigh in on Angelina Jolie’s breast cancer solution
- Focusing on Tumor-Activated Protein May Lead to Personalized Mesothelioma Treatment
- New algorithm maps cancer cells like nodes on a social network
- UK Aims To Make Genetic Testing Available To All Cancer Patients
- Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated
- Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors
- Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse
- Cancer Cause Directs Treatment 0314.2013-13.23
- Compound in Mediterranean diet makes cancer cells ‘mortal’
- Timing of cancer radiation therapy may minimize hair loss
- Hairdressers to boost cancer treatment fund
- Commonly used catheters double risk of blood clots in ICU and cancer patients
- Molecular marker from pancreatic ‘juices’ helps identify pancreatic cancer
- Nonmelanoma Skin Cancers Can Be Dangerous, Disfiguring and Deadly
- Samantha gets the chop for cancer charity
- Big Data Unveils Exciting Head and Neck Cancer Targets
- Lung Cancer Living Room 4-16-13
- Isabelle Daza talks about Cervical Cancer